HYDROXYZINE PAMOATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydroxyzine pamoate and what is the scope of freedom to operate?
Hydroxyzine pamoate
is the generic ingredient in three branded drugs marketed by Teva, Barr, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, Watson Labs, and Pfizer, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for hydroxyzine pamoate. Twenty-nine suppliers are listed for this compound.
Summary for HYDROXYZINE PAMOATE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 13 |
NDAs: | 37 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 29 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 1 |
Patent Applications: | 1,480 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for HYDROXYZINE PAMOATE |
Drug Sales Revenues: | Drug sales revenues for HYDROXYZINE PAMOATE |
What excipients (inactive ingredients) are in HYDROXYZINE PAMOATE? | HYDROXYZINE PAMOATE excipients list |
DailyMed Link: | HYDROXYZINE PAMOATE at DailyMed |
Recent Clinical Trials for HYDROXYZINE PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shalvata Mental Health Center | N/A |
Pharmacology for HYDROXYZINE PAMOATE
Drug Class | Antihistamine |
Mechanism of Action | Histamine Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYZINE PAMOATE
US Patents and Regulatory Information for HYDROXYZINE PAMOATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | HYDROXYZINE PAMOATE | hydroxyzine pamoate | CAPSULE;ORAL | 086705-001 | Jul 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | HYDROXYZINE PAMOATE | hydroxyzine pamoate | CAPSULE;ORAL | 086183-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Vangard | HYDROXYZINE PAMOATE | hydroxyzine pamoate | CAPSULE;ORAL | 088392-001 | Sep 19, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.